Schonfeld Strategic Advisors LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1665241
NEW YORK, NY
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,441,013
+$277,445 QoQ
Shares Held
2,901
+20.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#762
of 1,735 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Mar 31, 2024CallValue
$8,360,200
CallShares
20,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. VRTX ranks #67 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in VRTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,441,013 | 2,901 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $1,163,568 | 2,400 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,979,980 | 7,400 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $32,914,176 | 70,771 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $17,926,196 | 38,245 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,360,200 | 20,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $9,034,868 | 21,614 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $14,526,838 | 41,775 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $24,149,119 | 68,623 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $22,789,958 | 72,333 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,079,216 | 7,200 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,442,412 | 15,343 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $2,005,387 | 9,132 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,549,989 | 30,597 | Shares | Sole | 2021-11-16 | |
| 2021-03-31 | $8,025,711 | 37,348 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,380,043 | 22,764 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,585,643 | 5,827 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $1,354,876 | 4,667 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $868,517 | 3,650 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||